TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Non-Current Liabilities | ₹30 Cr | ₹13 Cr | ₹3.41 Cr | ₹0.45 Cr |
What is the latest Total Non-Current Liabilities ratio of TRIDENT LIFELINE ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹30 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹3.41 Cr |
| Mar2022 | ₹0.45 Cr |
How is Total Non-Current Liabilities of TRIDENT LIFELINE Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹30 Cr | 138.92 | |
| Mar2024 | ₹13 Cr | 273.03 | |
| Mar2023 | ₹3.41 Cr | 652.98 | |
| Mar2022 | ₹0.45 Cr | - | |
Compare Total Non-Current Liabilities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹312.9 Cr | 0.3% | 0.5% | -6.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,993.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 0.3% |
0.5% |
-6.3% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses